The prolyl-4-hydroxylase domain (PHD) oxygen sensor proteins hydroxylate hypoxiainducible transcription factor (HIF) α-subunits, leading to their subsequent ubiquitinylation and degradation. Since oxygen is a necessary co-substrate, a reduction in oxygen availability (hypoxia) decreases PHD activity and subsequent HIFα hydroxylation. Non-hydroxylated HIFα cannot be bound by the ubiquitin ligase von Hippel-Lindau tumor suppressor protein and HIFα proteins thus become stabilized. HIFα then heterodimerizes with HIFβ to form the functionally active HIF transcription factor complex which targets approximately 200 genes involved in adaptation to hypoxia. The three HIFα prolyl-4-hydroxylases are clearly of different nature compared with the prototype collagen prolyl-4-hydroxylase which hydroxylates a mass protein rather than a rare transcription factor. Thus, novel assays had to be developed to express and purify functionally active PHDs and to measure PHD activity in vitro. There is also a need for such assays to functionally distinguish the three different PHDs in terms of substrate specificity and drug function. We provide a detailed description of the expression and purification of the PHDs, as well as of a HIFα-dependent and a ΗΙFα-independent PHD assay.
Introduction
Cells sense changes in environmental oxygen availability by a group of enzymes which directly control the cellular response to low oxygen by destabilizing hypoxia-inducible factor (HIF) α subunits, the master transcriptional regulators of the hypoxic response. These oxygen sensing enzymes have alternatively been termed prolyl-4-hydroxylase domain (PHD), HIF prolyl hydroxylase (HPH) or egg laying defective nine homolog (EGLN). Up to date, three family members are known: PHD1/HPH3/EGLN2, PHD2/HPH2/EGLN1 and PHD3/HPH1/EGLN3 (Bruick, 2000; Epstein et al., 2001; Ivan et al., 2002) . PHDs hydroxylate HIF-1α and HIF-2α at two distinct proline residues within the HIFα oxygen-dependent degradation (ODD) domain (Fig. 1A) . Under normoxic conditions, prolyl-4-hydroxylation allows binding of the von HippelLindau tumor suppressor protein (pVHL), leading to polyubiquitinylation and proteasomal destruction (Schofield and Ratcliffe, 2004; Wenger, 2002) . Under hypoxic conditions, prolyl-4-hydroxylation is reduced, HIF-1α and HIF-2α become stabilized, heterodimerize with the constitutively expressed HIF-1β subunit aryl hydrocarbon receptor nuclear translocator (ARNT), and regulate the expression of a large number of effector genes involved in adaptation to low oxygen . In addition, factor inhibiting HIF (FIH) hydroxylates an asparagine residue within the C-terminal transactivation domain. Oxygen-dependent asparagine hydroxylation blocks the recruitment of the CBP/p300 transcriptional co-activators and thereby regulates the transcriptional activity of HIFs (Hewitson et al., 2002; Lando et al., 2002; Mahon et al., 2001 ).
PHDs do not represent static oxygen sensor molecules but rather are highly regulated themselves. Importantly, PHD2 and PHD3, but not PHD1, have been reported to be hypoxically induced at both the mRNA and protein levels (Epstein et al., 2001) . Accordingly, elevated PHD2 Wirthner et al., Determination and modulation of PHD activity 4 and PHD3 levels have been demonstrated in a broad panel of established cancer cell lines . Functional hypoxia response elements (HREs) are located in the promoter region of the human PHD2 gene as well as in the first intron of the human PHD3 gene, demonstrating that PHD2 and PHD3 are HIF target genes themselves (Metzen et al., 2005; Pescador et al., 2005) . Because the essential co-factor oxygen is basically lacking under hypoxic conditions, the HIF-dependent hypoxic increase in PHD abundance is somehow paradoxical and it has been suggested that PHD induction plays a role in accelerating the termination of the HIF response following re-oxygenation Aprelikova et al., 2004; Epstein et al., 2001; Marxsen et al., 2004) . Indeed, biochemical in vitro studies revealed K m values of purified PHDs for oxygen close to the oxygen partial pressure (pO 2 ) in air, suggesting that the kinetics of specific HIFα hydroxylation under hypoxic conditions are rather slow (Ehrismann et al., 2006; Hirsilä et al., 2003) . Of note, these K m values are critically dependent on the length of the target peptide (Koivunen et al., 2006) . However, tissues in situ have to deal with a great variability of generally very low pO 2 values, even when the inspiratory pO 2 is considered to be "normoxic". We recently showed that HIF-dependent regulation of PHD levels adapts the PHD-HIF oxygen sensing system to a given tissue pO 2 , rather than simply accelerating HIFα destruction following re-oxygenation (Stiehl et al., 2006) . Such a self-regulatory loop might define a tissue-specific threshold for HIFα-activation as a function of local pO 2 .
In addition to transcriptional regulation, PHD levels are also regulated by protein-protein interactions: the ubiquitin ligase Siah2 regulates PHD1 and PHD3, but not PHD2, protein stability (Nakayama et al., 2004) ; PHD3, but not PHD1 or PHD2, appears to be a substrate for the TRiC chaperonin (Masson et al., 2004) ; OS-9 apparently is simultaneously interacting with both HIFα and PHD2 or PHD3, but not PHD1, thereby enhancing HIFα hydroxylation and Wirthner et al., Determination and modulation of PHD activity 5 degradation (Baek et al., 2005) ; and Morg1 might provide the molecular scaffold for HIFα interaction specifically with PHD3 (Hopfer et al., 2006) . On the other hand, PHD2 has been shown to inhibit the transactivation function of HIF-1α in VHL-deficient cells (To and Huang, 2005) , a process that might involve PHD2-dependent recruitment of ING4, a likely component of a chromatin-remodeling complex (Ozer et al., 2005) .
These findings suggest two additional layers in oxygen signalling: first, abundance and function of PHDs actually can be regulated; and second, the three different PHDs are regulated in non-identical ways, further supporting their non-redundant roles in oxygen sensing. In fact, while all three PHDs can hydroxylate HIFα with similar efficiency in vitro, PHD2 has been suggested to play the main role for normoxic HIFα turnover in cultured cells (Berra et al., 2003) .
Consistent with these findings, PHD2 but neither PHD1 nor PHD3 knock-out mice die during embryonic development (Takeda et al., 2006) . Interestingly, a family with erythrocytosis due to a mutation in the gene encoding PHD2 has recently been reported (Percy et al., 2006) . The three PHDs are expressed in most organs but there are strikingly high levels of PHD3 and PHD1 mRNA expressed in the heart and testis, respectively (Stiehl et al., 2006; Willam et al., 2006) . PHD function can also be regulated by a number of endogenous small molecules as well as by a number of clinically relevant drugs: ascorbate (Knowles et al., 2003) , transition metals (Hirsilä et al., 2005; Martin et al., 2005) , Krebs cycle intermediates (Dalgard et al., 2004; Lu et al., 2005; Selak et al., 2005) and reactive oxygen species (ROS) including NO (BerchnerPfannschmidt et al., 2006; Gerald et al., 2004; Metzen et al., 2003) have been shown to influence or completely block the activity of the PHDs. Thus, molecular cross-talks appear to exist between oxygen homeostasis and transition metal homeostasis as well as cellular metabolism.
However, it is not completely understood how various transition metals and ascorbate interfere 6 with PHD and FIH function. The transition metals do not simply replace or oxidize the ferrous iron in the active center of the hydroxylases (Hirsilä et al., 2005; Martin et al., 2005) . At least cobalt and nickel might deplete intracellular ascorbate (Karaczyn et al., 2006; Salnikow et al., 2004) . As known for collagen hydroxylation, ascorbate is essential to reduce ferric iron in the active center of PHDs and FIH which occurs when oxidative decarboxylation of 2-oxoglutarate is uncoupled from target hydroxylation (McNeill et al., 2005; Myllylä et al., 1984) .
In addition to kinase signalling pathways, numerous reports appeared about an involvement of ROS in HIFα protein stabilization by either growth stimuli or hypoxia. Nonconclusive data were obtained so far about the source(s) of the ROS and whether hypoxia leads to an increase or decrease in ROS levels (Wenger, 2000) . However, ROS do have the potential to interfere with the complex process of protein hydroxylation. Indeed, the increase in ROS in junD -/-cells leads to a decrease in PHD activity and hence to HIF-1α accumulation (Gerald et al., 2004) . Apart from direct interference of ROS with the active center of oxygen sensing protein hydroxylases, also the re-direction of oxygen from mitochondria towards the protein hydroxylases might contribute to these effects (Hagen et al., 2003; Wenger, 2006) .
Due to the large therapeutical potential of PHD inhibitors in the treatment of anemic and ischemic diseases, several attempts to develop PHD antagonists are in progress. Currently, Noxyalylglycine (N-OG) and its cell-permeable derivative dimethyloxalylglycine (DMOG) are the commercially available PHD inhibitors of choice for experimental purposes. Apart from these co-substrate competitive inhibitors, iron chelators are very well known to induce HIF by PHD inhibition. These include desferoxamine (DFX) and ciclopirox olamine (CPX), two clinically relevant hydroxamic acid iron chelators (Linden et al., 2003) . In order to functionally investigate 7 the potency and mechanisms of available and future PHD inhibitors, there is a clear need for reliable methods to generate PHD proteins and to determine their activity.
Production of functionally active PHDs
Since bacterially expressed PHDs retain only little hydroxylase activity, PHDs were expressed and purified from baculovirally infected insect cells. To facilitate purification, the PHDs were tagged with either glutathione-S-transferase (GST), maltose-binding protein (MBP) or His 6 . According to our experience, best results were obtained with GST-tagged PHD proteins.
Thus, GST-tagged expression vectors were prepared by LR clonase-mediated homologous recombination of the corresponding pENTR vector, containing PHD1, PHD2 or PHD3 cDNA inserts, with the pDEST20 vector (Invitrogen). Recombined plasmids were transfected into the E. coli strain DH10BAC and the resulting bacmid plasmids were used to generate baculovirus stocks according to the manufacturer's instructions (Invitrogen). Spodoptera frugiperda (Sf) 9 cells were infected with baculovirus and cultured in Grace's insect medium (Invitrogen) at 27°C in a humidified incubator. Infected cells were grown for 80 to 110 hours, collected by centrifugation at 700 × g for 10 minutes at 4°C and washed with ice-cold PBS. Lysis was performed on ice for 10 minutes with 0.1% NP-40 in a buffer containing 10 mM Tris-HCl pH 7.4, 100 mM NaCl, 100 mM glycine, 100 µM dithiothreitol (DTT) and EDTA-free complete protease inhibitor cocktail (Roche). Crude lysate was cleared by centrifugation at 20,000 × g for 20 minutes at 4°C and the supernatant was incubated with glutathione-sepharose beads (previously washed with PBS) for at least 2 hours at 4°C with gentle agitation. After washing three times with PBS the protein was eluted with 15 mM reduced glutathione (GSH) in 50 mM
Tris-HCl pH 8.0 and 2 µM FeSO 4 . Eluted proteins were supplemented with 5% glycerol and Wirthner et al., Determination and modulation of PHD activity 8 stored in aliquots at -80°C. Purity was checked by SDS-PAGE followed by coomassie staining or immunoblotting (Fig. 1B) . Activity was routinely determined by the VHL binding assay described below (Fig. 1C) .
Determination of prolyl-4-hydroxylation by VHL binding to peptides derived from the HIF-1α ODD domain
Enzymatic activities of recombinant PHD proteins were determined by an in vitro hydroxylation assay based on a 96-well format as described previously (Oehme et al., 2004) .
Briefly, biotinylated synthetic peptides derived from human HIF-1α amino acids 556 to 574
(biotin-DLDLEALAPYIPADDDFQL), either wild-type, P564A mutant or hydroxylated (Hyp564), were bound to NeutrAvidin-coated 96-well plates (Pierce). All methionine residues were mutated to alanine residues in these peptides (M561A, M568A). Hydroxylase reactions using purified recombinant GST-tagged PHDs or cellular extracts were carried out for 1 hour at room temperature. A polycistronic bacterial expression vector for His 6 -tagged and thioredoxintagged pVHL/elongin B/elongin C (VBC) complex (kindly provided by S. Tan, Pennsylvania, PA) was used to express VBC in E. coli strain BL21AI followed by purification using nickel affinity chromatography (GE Healthcare), followed by gel filtration. The VBC complex was allowed to bind to the hydroxylated peptides for 15 minutes, anti-thioredoxin antibodies were added for 30 minutes, and horseradish peroxidase-coupled anti-rabbit antibodies (Sigma) were added for 30 minutes. Bound VBC complex was detected using the TMB (3,3',5,5'-tetramethylbenzidine) substrate kit (Pierce). The peroxidase reaction was stopped by adding one volume 2 M H 2 SO 4 and absorbance was determined at 450 nm in a microplate photometer. This assay is routinely used to determine the activity of the three GST-tagged PHD enzymes purified 9 from Sf9 insect cells (Fig. 1C) . Inter-assay comparability was guaranteed by calibration of each experiment to an internal standard curve using increasing fraction of synthetic hydroxyprolinecontaining peptides ( Fig. 2A ). When performed with pre-equilibrated solutions in a hypoxic glove box (Invivo2 400, Ruskinn Technology), this assay nicely demonstrates that PHD2 and PHD3 hydroxylase activities are functional over a wide range of physiologically relevant oxygen concentrations (Fig. 2B) . Furthermore, this assay is strictly dependent on the presence of P564 within the substrate peptide, and the iron chelator DFX as well as the substrate analog N-OG inhibit PHD-dependent prolyl-4-hydroxylation ( showed an increased PHD activity (Fig. 2D) . Similar results were obtained with HeLa cells (data not shown).
Determination of prolyl-4-hydroxylation by oxidative decarboxylation of 2-oxoglutarate
While the VHL binding assay is well suited to investigate PHD function, it is strictly dependent on VBC binding and hence unlikely to investigate the hydroxylation of potential novel non-HIFα targets. To overcome this problem, a 2-oxoglutarate to succinate conversion assay, originally developed to study collagen hydroxylation (Kaule and Günzler, 1990) (Hirsilä et al., 2003) . Because it is technically less demanding, the former technique is used in our laboratory. This assay was first applied for PHD measurements by Frelin and co-workers using "light mitochondrial rat kidney fractions" . We measured oxidative decarboxylation of 2-oxoglutarate by purified PHDs, because kidney extracts prepared according to Frelin and co-workers in fact solely showed high background activities, but did not contain measurable quantities of specific PHD activity (see below). Peptide (5-50 µM) or protein substrates (5 µM) were incubated with 0.1 µg GST-tagged PHD enzymes in 100 µl 50 mM Tris-HCl pH 7.4, 10 µM 2-oxoglutarate, 2 mM ascorbate, 100 µM DTT, 1 mg/ml BSA, 0.6 mg/ml catalase, 5 µM freshly prepared FeSO 4 and 50,000 -100,000 dpm [5-14 C]2-oxoglutarate with a specific activity of 50 mCi/mmol (HartmannAnalytic). The 2-oxoglutarate concentration can be varied from 10 to 100 µM, depending on the peptide/protein target concentration and the desired specific radioactivity. Generally, a 2-fold molar excess over the target concentration was used. Hydroxylation reactions were carried out for 24 hours at 37°C. To separate 2-oxoglutarate from succinate, 25 µl 20 mM succinate and 20 mM 2-oxoglutarate were added and mixed by vortexing. Subsequently, 25 µl 0.16 M 2,4-dinitrophenyl hydrazine in 30% HClO 4 were added. After incubation at room temperature for 30 minutes, 50 µl of 1 M 2-oxoglutarate was added to remove residual 2,4-dinitrophenyl hydrazine, and the reaction was allowed to proceed for another 30 minutes at room temperature. Following 11 centrifugation at 20,000 × g for 15 minutes at 4°C, 150 µl supernatant was carefully removed, mixed with 3 ml scintillation cocktail (PerkinElmer), and the amount of [ 14 C]succinate was determined by liquid scintillation counting in a β-counter (TRI-CARB 2900TR, Packard).
As depicted in Fig. 3A , using recombinant GST-PHD2 this assay shows a linear relationship between the availability of a HIF-1α ODD domain-derived synthetic peptide substrate and [ 14 C]succinate production in the range from 8 to 50 µM peptide. Below 5 µM, however, only background values were obtained. This assay is strictly dependent on the presence of 1 mM ascorbate as well as a peptide substrate containing the wild-type P564 (Fig. 3B) . The lack of a substrate peptide or the mutation of the critical proline (P564A) results in background 2-oxoglutarate conversion.
Crude tissue extracts are not a suitable source of PHD activity for the 2-oxoglutarate conversion assay.
Earlier reports suggested the use of "light mitochondrial rat kidney fractions" as a source for PHD activity in this type of assay . We therefore prepared rat kidney extracts according to this protocol and tested them for PHD activity. As shown in Fig. 4A , 2-oxoglutarate conversion was indeed stimulated by these extracts. However, a very high background activity was also observed in the absence of the HIF-1α ODD domain-derived peptide and the presence of the wild-type peptide stimulated 2-oxoglutarate conversion only moderately. To ensure PHD-dependent 2-oxoglutarate conversion, ample amounts of the known PHD inhibitors DFX and N-OG (see Fig. 2C ) or CuCl 2 (Martin et al., 2005) were added to the reaction mix. Surprisingly, none of these PHD inhibitors blocked 2-oxoglutarate conversion, whether the substrate peptide was present or not (Fig. 4A, left panel) .
Moreover, the presence of a P564A mutant peptide stimulated 2-oxoglutarate conversion as well as the wild-type peptide (Fig. 4A, right panel) . The P564A mutant peptide cannot be hydroxylated and shows no VBC complex binding after incubation with purified PHDs (Figs. 2C and 3B). Therefore, these experiments clearly demonstrate that "light mitochondrial rat kidney fractions" do not represent a source of specific PHD activity but rather contain high levels of enzymes unspecifically metabolising 2-oxoglutarate. A similar lack of specific (i.e. PHDdependent) 2-oxoglutarate conversion was observed with crude extracts derived from HeLa, others contained up to 30% of an impurity that co-migrated with the succinate standard (Fig. 4B, right panel). Regarding the relatively low specific PHD activities and the rather high unspecific background 2-oxoglutarate conversion, such high impurities are not acceptable in this type of assay.
Application of the 2-oxoglutarate conversion assay to protein targets
In order to be useful for putative novel PHD substrate proteins without prior knowledge of the actual target prolyl residue, the 2-oxoglutarate conversion assay needs to work also with proteins rather than only with synthetic peptides. To demonstrate the feasibility of this approach, wild-type GST-HIF2αODD (aa 404-569, MW = 46 kDa) and P405A/P531A double-mutant GST-HIF2αODD protein fragments were expressed in E.coli BL21AI by induction with 0.2% arabinose for 4 hours at 37°C. After harvesting by centrifugation, the bacteria were lysed with a high pressure cell disrupter (Basic-Z, Constant Systems) in the prescence of EDTA-free complete protease inhibitor cocktail (Roche). Purification of the GST-tagged protein was carried out using affinity chromatography on glutathione sepharose beads (Amersham-GE Healthcare)
as described above (see Fig. 1B ). Purity of the recombinant protein fragments was checked by SDS-PAGE followed by coomassie staining or immunoblotting (Fig. 5A ). When compared with a HIF-1αODD-derived wild-type peptide, equimolar concentrations of the HIF2αODD protein fragment also stimulated PHD1-dependent 2-oxoglutarate conversion, albeit to a somewhat lower extent (Fig. 5B ).
Conclusions
The PHD-dependent hydroxylation assay presented here works independently of already known peptide sequences or VHL binding. It should thus be possible to use this assay for the investigation of putative novel, non-HIFα PHD substrates as well. In addition, even if not shown here, the same assay should principally also be applicable to novel FIH substrates and might become useful for screening for novel hydroxylation targets. Whereas no non-HIFα PHD hydroxylation targets have been reported thus far, FIH has recently been shown to hydroxylate a number of proteins containing ankyrin repeats, including NF-κB and IκBα (Cockman et al., 2006) . We expect a similar widening of the spectrum of PHD targets. In addition, PHDdependent hydroxylation assays will be required to study novel drugs that modulate PHD activity and hence will become important for the treatment of anemic and ischemic disease. 
